$PETS
PETMED EXPRESS INC

2023 Q4 Form 10-Q Financial Statement

#000104013023000080 Filed on October 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $65.32M $71.00M
YoY Change 10.95% 8.57%
Cost Of Revenue $47.43M $50.94M
YoY Change 8.71% 8.51%
Gross Profit $17.88M $20.06M
YoY Change 17.36% 8.73%
Gross Profit Margin 27.38% 28.26%
Selling, General & Admin $19.19M $18.79M
YoY Change 27.35% 28.42%
% of Gross Profit 107.29% 93.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.770M $1.713M
YoY Change 88.1% 99.65%
% of Gross Profit 9.9% 8.54%
Operating Expenses $20.96M $20.50M
YoY Change 30.92% 32.36%
Operating Profit -$3.074M -$441.0K
YoY Change 299.74% -114.89%
Interest Expense $136.0K $570.0K
YoY Change -80.79% 46.91%
% of Operating Profit
Other Income/Expense, Net $429.0K $824.0K
YoY Change -55.64% 26.96%
Pretax Income -$2.645M $383.0K
YoY Change -1435.86% -89.39%
Income Tax -$600.0K $500.0K
% Of Pretax Income 130.55%
Net Earnings -$2.027M -$70.00K
YoY Change 10568.42% -102.71%
Net Earnings / Revenue -3.1% -0.1%
Basic Earnings Per Share -$0.10 $0.00
Diluted Earnings Per Share -$0.10 $0.00
COMMON SHARES
Basic Shares Outstanding 21.15M shares 21.17M shares
Diluted Shares Outstanding 20.43M shares 20.38M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.44M $53.50M
YoY Change -51.73% -44.59%
Cash & Equivalents $49.40M $53.50M
Short-Term Investments
Other Short-Term Assets $9.602M $11.10M
YoY Change 32.53% 83.23%
Inventory $34.58M $18.90M
Prepaid Expenses
Receivables $1.930M $2.174M
Other Receivables $0.00 $0.00
Total Short-Term Assets $95.55M $85.66M
YoY Change -28.7% -38.02%
LONG-TERM ASSETS
Property, Plant & Equipment $26.81M $26.97M
YoY Change 6.22% 7.06%
Goodwill $26.66M $22.45M
YoY Change
Intangibles $11.69M $12.18M
YoY Change
Long-Term Investments $5.300M
YoY Change
Other Assets $5.715M $5.200M
YoY Change
Total Long-Term Assets $77.80M $73.61M
YoY Change 150.15% 137.08%
TOTAL ASSETS
Total Short-Term Assets $95.55M $85.66M
Total Long-Term Assets $77.80M $73.61M
Total Assets $173.4M $159.3M
YoY Change 4.98% -5.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.85M $25.38M
YoY Change 59.77% 5.83%
Accrued Expenses $30.48M $11.70M
YoY Change 351.3% 77.68%
Deferred Revenue $3.100M $3.600M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $72.40M $40.70M
YoY Change 133.01% 33.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $890.0K $3.825M
YoY Change
Total Long-Term Liabilities $890.0K $3.825M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $72.40M $40.70M
Total Long-Term Liabilities $890.0K $3.825M
Total Liabilities $73.29M $45.60M
YoY Change 132.4% 46.57%
SHAREHOLDERS EQUITY
Retained Earnings $76.56M $91.88M
YoY Change -34.52% -25.45%
Common Stock $21.00K $21.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.1M $113.7M
YoY Change
Total Liabilities & Shareholders Equity $173.4M $159.3M
YoY Change 4.98% -5.9%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.027M -$70.00K
YoY Change 10568.42% -102.71%
Depreciation, Depletion And Amortization $1.770M $1.713M
YoY Change 88.1% 99.65%
Cash From Operating Activities -$2.588M -$780.0K
YoY Change -119.95% -38.68%
INVESTING ACTIVITIES
Capital Expenditures $1.120M $990.0K
YoY Change 12.79% -173.12%
Acquisitions
YoY Change
Other Investing Activities -$299.0K $0.00
YoY Change
Cash From Investing Activities -$1.419M -$990.0K
YoY Change 42.9% -26.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.00K -6.300M
YoY Change -99.69% 0.93%
NET CHANGE
Cash From Operating Activities -2.588M -780.0K
Cash From Investing Activities -1.419M -990.0K
Cash From Financing Activities -19.00K -6.300M
Net Change In Cash -4.026M -8.070M
YoY Change -168.45% -9.0%
FREE CASH FLOW
Cash From Operating Activities -$2.588M -$780.0K
Capital Expenditures $1.120M $990.0K
Free Cash Flow -$3.708M -$1.770M
YoY Change -130.96% -2258.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10986000 usd
CY2023Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
11289000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
757000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3573000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
40695000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
36497000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1080000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3825000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3825000 usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2500 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2500 shares
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
570000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
388000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1190000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
505000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-943000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
590000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-383000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
579000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-215000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5108000 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
0 usd
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
5000000 usd
us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3600000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3600000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
70999000 usd
CY2023Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65394000 usd
CY2022Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
CY2023Q3 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
5605000 usd
CY2023Q3 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.086
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
149243000 usd
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
135581000 usd
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
13662000 usd
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.101
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-70000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2579000 usd
us-gaap Net Income Loss
NetIncomeLoss
-957000 usd
us-gaap Net Income Loss
NetIncomeLoss
5354000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20382979 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20261114 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20357752 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20234904 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72741 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
72493 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10125 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10125 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20382979 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20343980 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20357752 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20317522 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53500000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104100000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13160000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
979000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12181000 usd
CY2023Q3 pets Intangible And Other Assets Gross
IntangibleAndOtherAssetsGross
18160000 usd
CY2023Q3 pets Intangibles And Other Assets Accumulated Amortization
IntangiblesAndOtherAssetsAccumulatedAmortization
979000 usd
CY2023Q3 pets Intangible And Other Assets
IntangibleAndOtherAssets
17181000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
860000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 usd
CY2023Q1 pets Intangible And Other Assets Gross
IntangibleAndOtherAssetsGross
5860000 usd
CY2023Q1 pets Intangibles And Other Assets Accumulated Amortization
IntangiblesAndOtherAssetsAccumulatedAmortization
0 usd
CY2023Q1 pets Intangible And Other Assets
IntangibleAndOtherAssets
5860000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.038
us-gaap Operating Lease Cost
OperatingLeaseCost
431000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
28000 usd
us-gaap Lease Cost
LeaseCost
459000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
419000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2220000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
412000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
501000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
488000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
502000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
42000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1945000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
108000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1837000 usd
CY2023 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
7800000 usd
pets Payments Of Excise And Sales Taxes
PaymentsOfExciseAndSalesTaxes
700000 usd
pets Increase Decrease In Sales Taxes Payable
IncreaseDecreaseInSalesTaxesPayable
300000 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
6800000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.183
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.546
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001040130-23-000080-index-headers.html Edgar Link pending
0001040130-23-000080-index.html Edgar Link pending
0001040130-23-000080.txt Edgar Link pending
0001040130-23-000080-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20230930.htm Edgar Link pending
pets-20230930.xsd Edgar Link pending
pets-20230930xexx311.htm Edgar Link pending
pets-20230930xexx312.htm Edgar Link pending
pets-20230930xexx321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
pets-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pets-20230930_lab.xml Edgar Link unprocessable
pets-20230930_pre.xml Edgar Link unprocessable
pets-20230930_def.xml Edgar Link unprocessable
pets-20230930_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending